Notable Insider Buys Of The Past Week: Harley-Davidson, Texas Instruments And More
Notable Insider Buys Of The Past Week: Harley-Davidson, Texas Instruments And More
- Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty.
- Some insiders have been taking advantage of secondary offerings recently.
- Others have been adding to their stakes in the wake of earnings reports.
- 對於潛在投資者來説，內幕收購可能是一個令人鼓舞的信號，尤其是在市場面臨不確定性的情況下。
- 一些內部人士最近一直在利用二次發行的機會。
- 在財報公佈後，其他公司一直在增持股份。
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and want to profit from it. So insider buying can be an encouraging signal for potential investors, particularly when there is uncertainty in the markets. Note that with earnings reporting season in full swing, buy windows for many insiders are closed.
傳統觀點認為，內部人士和10%的股東購買一家公司的股票實際上只有一個原因--他們相信股價會上漲，並希望從中獲利。所以內幕收購對於潛在投資者來説，這可能是一個令人鼓舞的信號，特別是在市場存在不確定性的情況下。請注意，隨着財報季節的全面展開，許多內部人士的買入窗口都關閉了。
Here are some of the most noteworthy insider purchases that were reported in the past week.
以下是過去一週報道的一些最值得注意的內幕交易。
Outlook Therapeutics Inc (NASDAQ:OTLK) had a 10% owner and a director both increase their stakes last week. They acquired 11.36 million shares altogether, at a secondary offering price of $1 per share. The stock closed most recently at $2.18 per share.
Outlook治療公司(納斯達克：OTLK)和董事(Sequoia Capital)上週均增持股份。他們總共收購了1136萬股，二次發行價為每股1美元。該股最近的收盤價為每股2.18美元。
A beneficial owner recently indirectly acquired around 4.22 million Vyne Therapeutics Inc (NASDAQ:VYNE) shares at $2.37 apiece. That totaled about $10 million and boosted the owner's stake to over 27.09 million shares. The stock closed most recently at $2.75 per share, after popping 39% for the week.
一位實益所有者最近間接購買了約422萬Vyne治療公司(納斯達克：韋恩)每股2.37美元。這筆資金總計約1,000萬美元，將股東的持股比例推高至2,709萬股以上。該股最新收盤價為每股2.75美元，本週累計上漲39%。
A pair of 10% owners have picked up almost 363,900 shares altogether of Bridge Bancorp, Inc. (NASDAQ:BDGE). That cost them more than $8.53 million, at prices ranging from $25.28 to $26.24 per share. Note that Bridge Bancorp completed its merger with Dime Community Bancshares early last week.
一對10%的所有者總共購買了近36.39萬股Bridge Bancorp，Inc.(納斯達克：BDGE)。這讓他們損失了超過853萬美元，價格從每股25.28美元到26.24美元不等。請注意，Bridge Bancorp上週初完成了與Dime Community BancShares的合併。
The CEO at Surgalign Holdings Inc (NASDAQ:SRGA), another executive and four directors all took advantage of a public offering. Altogether, they acquired almost 3.66 million shares at $1.50 apiece. That cost that them over $5.48 million. The stock was last seen trading at $2.67 a share.
這位首席執行官在蘇加林控股公司(納斯達克：SRGA)，另一名高管和四名董事都利用了公開募股。他們總共以每股1.5美元的價格收購了近366萬股。這讓他們損失了超過548萬美元。該股上一次出現的交易價格為每股2.67美元。
MSC Industrial Direct Co Inc (NYSE:MSM) saw a director recently acquire nearly 67,800 shares. At share prices that ranged from $77.72 to $78.26, the total for the purchase came to around $5.29 million. Shares ended this past week trading at $85.64. An executive purchased almost 4,300 shares last week as well.
MSC工業直銷公司紐約證券交易所代碼：男男性接觸者)最近，一家董事收購了近67,800股。以77.72美元至78.26美元的股價計算，此次收購的總金額約為529萬美元。過去一週，該公司股價收於85.64美元。一位高管上週也購買了近4300股。
A beneficial owner last week bought 130,000 Evelo Biosciences Inc (NASDAQ:EVLO) shares at a secondary offering price of $15 apiece. The total for that came to about $1.95 million, and it boosted the owner's stake to more than 4.12 million shares. The stock ended last week trading at $16.99 per share.
一位實益所有者上週購買了13萬Evelo生物科學公司(納斯達克：EVLO)股票，二次發行價為每股15美元。這筆交易的總金額約為195萬美元，使股東持有的股份增加到412萬股以上。該股上週收盤時為每股16.99美元。
CEO Jochen Zeitz added 30,800 more Harley-Davidson Inc (NYSE:HOG) shares to his stake in the wake of a disappointing quarterly report last week. At prices ranging from $32.42 to $32.49 per share, that totaled around $1 million. The share price retreated about 15% last week to end at $33.69, still above Zeitz' purchase price range.
首席執行官Jochen Zeitz又增加了30,800人哈雷-戴維森公司紐約證券交易所代碼：小豬)在上週發佈了令人失望的季度報告後，他將股票出售給了他的股份。以每股32.42美元至32.49美元的價格計算，這筆交易總額約為100萬美元。該公司股價上週回落約15%，收於33.69美元，仍高於Zeitz的收購價區間。
One Texas Instruments Incorporated (NASDAQ:TXN) director bucked the recent insider selling trend by adding less than 6,000 shares. At prices between $166.78 and $167 per share, that cost him almost $997,300. Note that this insider activity followed a better than expected fourth-quarter report.
一德州儀器公司(納斯達克：TXN)董事逆勢增持不到6,000股內幕股票。以每股166.78美元至167萬美元的價格計算，這讓他損失了近997,300美元。請注意，這種內幕活動是在第四季度報告好於預期之後發佈的。
Brown & Brown, Inc. (NYSE:BRO) had a director step up and buy the recent dip. The 10,000 shares he acquired, at share prices of between $43.35 and $43.40, added up to almost $433,800. This insurer also recently posted better than expected earnings, and its shares closed most recently at $44.77 apiece.
Brown&Brown公司紐約證券交易所代碼：哥們兒)有一隻董事上漲並買入了最近的下跌。他以43.35美元至43.40美元的股價收購了1萬股，總計近43.38萬美元。這家保險公司最近也公佈了好於預期的收益，其股價最近收於每股44.77美元。
And Alliance Data Systems Corporation (NYSE:ADS) saw an independent director acquire via trust some 6,000 shares. At a share price of about $68.46, that added up to more than $410,700. The stock ended Friday trading at $84.86 per share, after a pop of more than 24% last week.
和聯合數據系統公司紐約證券交易所代碼：廣告)看到一家獨立的董事通過信託收購了約6,000股。以大約68.46美元的股價計算，這筆錢加起來超過了410,700美元。該股上週五收盤報84.86美元，上週漲幅超過24%。
Note that some smaller amount of insider buying at Accuray Incorporated (NASDAQ:ARAY), Charles Schwab Corporation (NYSE:SCHW), Consolidated Edison, Inc. (NYSE:ED), Crown Castle International Corp (NYSE:CCI) and Cullen/Frost Bankers, Inc. (NYSE:CFR) was reported in the past week as well.
At the time of this writing, the author had no position in the mentioned equities.
在撰寫本文時，作者並未持有上述股票的頭寸。
Keep up with all the latest breaking news and trading ideas by following Benzinga on Twitter.
通過關注Benzinga on，瞭解所有最新的突發新聞和交易想法推特.
Photo by Texas Instruments via Wikimedia.
圖片來源：德州儀器通過維基媒體.
譯文內容由第三人軟體翻譯。